Report Detail
Global and Human Somatotropin Market Insights, Forecast to 2026
- RnM4192232 |
- 07 September, 2020 |
- Global |
- 140 Pages |
- QYResearch |
- Pharma & Healthcare
Human Somatotropin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Somatotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment 2, the Human Somatotropin market is segmented into
Powder
Solvent
Segment 7, the Human Somatotropin market is segmented into
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Regional and Country-level Analysis
The Human Somatotropin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Somatotropin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast 2, and 7 segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Somatotropin Market Share Analysis
Human Somatotropin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Somatotropin business, the date to enter into the Human Somatotropin market, Human Somatotropin product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
1 Study Coverage
- 1.1 Human Somatotropin Product Introduction
- 1.2 Market Segments
- 1.3 Key Human Somatotropin Manufacturers Covered: Ranking by Revenue
- 1.4 Market 2
- 1.4.1 Global Human Somatotropin Market Size Growth Rate 2
- 1.4.2 Powder
- 1.4.3 Solvent
- 1.5 Market 7
- 1.5.1 Global Human Somatotropin Market Size Growth Rate 7
- 1.5.2 Growth Hormone Deficiency (GHD)
- 1.5.3 Turner Syndrome
- 1.5.4 Chronic Renal Insufficiency
- 1.5.5 Prader Willi Syndrome
- 1.5.6 Small for Gestational Age
- 1.5.7 SHOX Deficiency
- 1.5.8 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Somatotropin Market Size, Estimates and Forecasts
- 2.1.1 Global Human Somatotropin Revenue 2015-2026
- 2.1.2 Global Human Somatotropin Sales 2015-2026
- 2.2 Global Human Somatotropin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Human Somatotropin Historical Market Size by Region (2015-2020)
- 2.3.1 Global Human Somatotropin Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Human Somatotropin Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Human Somatotropin Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Human Somatotropin Sales Forecast by Region (2021-2026)
- 2.4.2 Global Human Somatotropin Revenue Forecast by Region (2021-2026)
3 Global Human Somatotropin Competitor Landscape by Players
- 3.1 Global Top Human Somatotropin Sales by Manufacturers
- 3.1.1 Global Human Somatotropin Sales by Manufacturers (2015-2020)
- 3.1.2 Global Human Somatotropin Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Human Somatotropin Manufacturers by Revenue
- 3.2.1 Global Human Somatotropin Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Human Somatotropin Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2019
- 3.2.5 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Human Somatotropin Price by Manufacturers
- 3.4 Global Human Somatotropin Manufacturing Base Distribution, Product Types
- 3.4.1 Human Somatotropin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Somatotropin Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Somatotropin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size 2 (2015-2026)
- 4.1 Global Human Somatotropin Market Size 2 (2015-2020)
- 4.1.1 Global Human Somatotropin Sales 2 (2015-2020)
- 4.1.2 Global Human Somatotropin Revenue 2 (2015-2020)
- 4.1.3 Human Somatotropin Average Selling Price (ASP) 2 (2015-2026)
- 4.2 Global Human Somatotropin Market Size Forecast 2 (2021-2026)
- 4.2.1 Global Human Somatotropin Sales Forecast 2 (2021-2026)
- 4.2.2 Global Human Somatotropin Revenue Forecast 2 (2021-2026)
- 4.2.3 Human Somatotropin Average Selling Price (ASP) Forecast 2 (2021-2026)
- 4.3 Global Human Somatotropin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size 7 (2015-2026)
- 5.1 Global Human Somatotropin Market Size 7 (2015-2020)
- 5.1.1 Global Human Somatotropin Sales 7 (2015-2020)
- 5.1.2 Global Human Somatotropin Revenue 7 (2015-2020)
- 5.1.3 Human Somatotropin Price 7 (2015-2020)
- 5.2 Human Somatotropin Market Size Forecast 7 (2021-2026)
- 5.2.1 Global Human Somatotropin Sales Forecast 7 (2021-2026)
- 5.2.2 Global Human Somatotropin Revenue Forecast 7 (2021-2026)
- 5.2.3 Global Human Somatotropin Price Forecast 7 (2021-2026)
6 by Players, and
- 6.1 Human Somatotropin Market Size YoY Growth 2015-2026
- 6.1.1 Human Somatotropin Sales YoY Growth 2015-2026
- 6.1.2 Human Somatotropin Revenue YoY Growth 2015-2026
- 6.1.3 Human Somatotropin Market Share in Global Market 2015-2026
- 6.2 Human Somatotropin Market Size by Players (International and Local Players)
- 6.2.1 Top Human Somatotropin Players by Sales (2015-2020)
- 6.2.2 Top Human Somatotropin Players by Revenue (2015-2020)
- 6.3 Human Somatotropin Historic Market Review 2 (2015-2020)
- 6.3.1 Human Somatotropin Sales Market Share 2 (2015-2020)
- 6.3.2 Human Somatotropin Revenue Market Share 2 (2015-2020)
- 6.3.3 Human Somatotropin Price 2 (2015-2020)
- 6.4 Human Somatotropin Market Estimates and Forecasts 2 (2021-2026)
- 6.4.1 Human Somatotropin Sales Forecast 2 (2021-2026)
- 6.4.2 Human Somatotropin Revenue Forecast 2 (2021-2026)
- 6.4.3 Human Somatotropin Price Forecast 2 (2021-2026)
- 6.5 Human Somatotropin Historic Market Review 7 (2015-2020)
- 6.5.1 Human Somatotropin Sales Market Share 7 (2015-2020)
- 6.5.2 Human Somatotropin Revenue Market Share 7 (2015-2020)
- 6.5.3 Human Somatotropin Price 7 (2015-2020)
- 6.6 Human Somatotropin Market Estimates and Forecasts 7 (2021-2026)
- 6.6.1 Human Somatotropin Sales Forecast 7 (2021-2026)
- 6.6.2 Human Somatotropin Revenue Forecast 7 (2021-2026)
- 6.6.3 Human Somatotropin Price Forecast 7 (2021-2026)
7 North America
- 7.1 North America Human Somatotropin Market Size YoY Growth 2015-2026
- 7.2 North America Human Somatotropin Market Facts & Figures by Country
- 7.2.1 North America Human Somatotropin Sales by Country (2015-2020)
- 7.2.2 North America Human Somatotropin Revenue by Country (2015-2020)
- 7.2.3 United States
- 7.2.4 Canada
- 7.2.5 Mexico
8 Europe
- 8.1 Europe Human Somatotropin Market Size YoY Growth 2015-2026
- 8.2 Europe Human Somatotropin Market Facts & Figures by Country
- 8.2.1 Europe Human Somatotropin Sales by Country
- 8.2.2 Europe Human Somatotropin Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 UK
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Human Somatotropin Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Human Somatotropin Market Facts & Figures by Country
- 9.2.1 Asia Pacific Human Somatotropin Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Human Somatotropin Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Indonesia
- 9.2.9 Thailand
- 9.2.10 Malaysia
- 9.2.11 Philippines
- 9.2.12 Vietnam
10 Latin America
- 10.1 Latin America Human Somatotropin Market Size YoY Growth 2015-2026
- 10.2 Latin America Human Somatotropin Market Facts & Figures by Country
- 10.2.1 Latin America Human Somatotropin Sales by Country
- 10.2.2 Latin America Human Somatotropin Revenue by Country
- 10.2.3 Brazil
11 Middle East and Africa
- 11.1 Middle East and Africa Human Somatotropin Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Human Somatotropin Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Human Somatotropin Sales by Country
- 11.2.2 Middle East and Africa Human Somatotropin Revenue by Country
- 11.2.3 Turkey
- 11.2.4 GCC Countries
- 11.2.5 Egypt
- 11.2.6 South Africa
12 Company Profiles
- 12.1 Novo Nordisk
- 12.1.1 Novo Nordisk Corporation Information
- 12.1.2 Novo Nordisk Description and Business Overview
- 12.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Novo Nordisk Human Somatotropin Products Offered
- 12.1.5 Novo Nordisk Recent Development
- 12.2 Pfizer
- 12.2.1 Pfizer Corporation Information
- 12.2.2 Pfizer Description and Business Overview
- 12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Pfizer Human Somatotropin Products Offered
- 12.2.5 Pfizer Recent Development
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Corporation Information
- 12.3.2 Eli Lilly Description and Business Overview
- 12.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Eli Lilly Human Somatotropin Products Offered
- 12.3.5 Eli Lilly Recent Development
- 12.4 Merck Serono
- 12.4.1 Merck Serono Corporation Information
- 12.4.2 Merck Serono Description and Business Overview
- 12.4.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Merck Serono Human Somatotropin Products Offered
- 12.4.5 Merck Serono Recent Development
- 12.5 F. Hoffmann-La Roche
- 12.5.1 F. Hoffmann-La Roche Corporation Information
- 12.5.2 F. Hoffmann-La Roche Description and Business Overview
- 12.5.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
- 12.5.5 F. Hoffmann-La Roche Recent Development
- 12.6 Ferring Pharmaceuticals
- 12.6.1 Ferring Pharmaceuticals Corporation Information
- 12.6.2 Ferring Pharmaceuticals Description and Business Overview
- 12.6.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
- 12.6.5 Ferring Pharmaceuticals Recent Development
- 12.7 GeneScience Pharmaceuticals
- 12.7.1 GeneScience Pharmaceuticals Corporation Information
- 12.7.2 GeneScience Pharmaceuticals Description and Business Overview
- 12.7.3 GeneScience Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
- 12.7.5 GeneScience Pharmaceuticals Recent Development
- 12.8 Ipsen
- 12.8.1 Ipsen Corporation Information
- 12.8.2 Ipsen Description and Business Overview
- 12.8.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Ipsen Human Somatotropin Products Offered
- 12.8.5 Ipsen Recent Development
- 12.9 LG Life Sciences
- 12.9.1 LG Life Sciences Corporation Information
- 12.9.2 LG Life Sciences Description and Business Overview
- 12.9.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 LG Life Sciences Human Somatotropin Products Offered
- 12.9.5 LG Life Sciences Recent Development
- 12.10 Sandoz International
- 12.10.1 Sandoz International Corporation Information
- 12.10.2 Sandoz International Description and Business Overview
- 12.10.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Sandoz International Human Somatotropin Products Offered
- 12.10.5 Sandoz International Recent Development
- 12.11 Novo Nordisk
- 12.11.1 Novo Nordisk Corporation Information
- 12.11.2 Novo Nordisk Description and Business Overview
- 12.11.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Novo Nordisk Human Somatotropin Products Offered
- 12.11.5 Novo Nordisk Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Human Somatotropin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Somatotropin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Somatotropin. Industry analysis & Market Report on Human Somatotropin is a syndicated market report, published as Global and Human Somatotropin Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Human Somatotropin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
